Monday, 12 Sep 2022 | Funding Deadline
Translational Awards aim to progress the development of novel, innovative technologies towards benefits to human cardiovascular health. The scheme supports the development of technologies with transformative potential from the proof-of-concept stage to being ready for the commercial market. Proposals are expected to demonstrate a strong intellectual property position and a development proposition that could attract follow-on investment.
The project should be novel and inventive and address an unmet clinical need within the BHF remit. The project should result in a product, technology or intervention that is ready for market development. The project should be milestone-driven and have a credible delivery plan.
Deadline for proposals: 12 September 2022
Find out more here